Clinical Trial Update: Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for alemtuzumab in chronic lymphocytic leukemia across Phase 1 and Phase 2 shows completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Alemtuzumab (Alemtuzumab)

Snippet

Sponsor: German CLL Study Group | Conditions: Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: COMPLETED